Abstract
The role of the vascular endothelium in activation of the coagulation system, a fundamental homeostatic mechanism of mammalian biology, is uncertain because there is little evidence indicating that endothelial cells in vivo express tissue factor (TF), the system's triggering mechanism. As a surrogate for vessel wall endothelium, we examined circulating endothelial cells (CEC) from normals and patients with sickle cell anemia, a disease associated with activation of coagulation. We find that sickle CEC abnormally express TF antigen (expressed as percent CEC that are TF-positive), with 66+/-13% positive in sickle patients in steady-state, 83+/-19% positive in sickle patients presenting with acute vasoocclusive episodes, and only 10+/-13% positive in normal controls. Repeated samplings confirmed this impression that TF expression is greater when sickle patients develop acute vasoocclusive episodes. Sickle CEC are also positive for TF mRNA, with excellent concurrence between antigen and mRNA expression. The TF expressed on the antigen-positive CEC is functional, as demonstrated by a binding assay for Factor VIIa and a chromogenic assay sensitive to generation of Factor Xa. By establishing that endothelial cells in vivo can express TF, these data imply that the vast endothelial surface area does provide an important pathophysiologic trigger for coagulation activation.
Full Text
The Full Text of this article is available as a PDF (216.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Contrino J., Hair G., Kreutzer D. L., Rickles F. R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996 Feb;2(2):209–215. doi: 10.1038/nm0296-209. [DOI] [PubMed] [Google Scholar]
- Drake T. A., Cheng J., Chang A., Taylor F. B., Jr Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol. 1993 May;142(5):1458–1470. [PMC free article] [PubMed] [Google Scholar]
- Drake T. A., Morrissey J. H., Edgington T. S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989 May;134(5):1087–1097. [PMC free article] [PubMed] [Google Scholar]
- Edgington T. S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991 Jul 12;66(1):67–79. [PubMed] [Google Scholar]
- Edgington T. S., Mackman N., Fan S. T., Ruf W. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Hematol. 1992;34 (Suppl):S15–S27. [PubMed] [Google Scholar]
- Faulk W. P., Labarrere C. A., Carson S. D. Tissue factor: identification and characterization of cell types in human placentae. Blood. 1990 Jul 1;76(1):86–96. [PubMed] [Google Scholar]
- Francis R. B., Jr Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis. 1989;19(2):105–111. doi: 10.1159/000215901. [DOI] [PubMed] [Google Scholar]
- Furie B., Furie B. C. The molecular basis of blood coagulation. Cell. 1988 May 20;53(4):505–518. doi: 10.1016/0092-8674(88)90567-3. [DOI] [PubMed] [Google Scholar]
- Jaffe E. A. Cell biology of endothelial cells. Hum Pathol. 1987 Mar;18(3):234–239. doi: 10.1016/s0046-8177(87)80005-9. [DOI] [PubMed] [Google Scholar]
- Kurantsin-Mills J., Ofosu F. A., Safa T. K., Siegel R. S., Lessin L. S. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol. 1992 Aug;81(4):539–544. doi: 10.1111/j.1365-2141.1992.tb02989.x. [DOI] [PubMed] [Google Scholar]
- Leatham E. W., Bath P. M., Tooze J. A., Camm A. J. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995 Jan;73(1):10–13. doi: 10.1136/hrt.73.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mesters R. M., Mannucci P. M., Coppola R., Keller T., Ostermann H., Kienast J. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood. 1996 Aug 1;88(3):881–886. [PubMed] [Google Scholar]
- Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol. 1992 Jul;29(3):170–176. [PubMed] [Google Scholar]
- Panoskaltsis-Mortari A., Bucy R. P. In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. Biotechniques. 1995 Feb;18(2):300–307. [PubMed] [Google Scholar]
- Ruf W., Rehemtulla A., Morrissey J. H., Edgington T. S. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem. 1991 Feb 5;266(4):2158–2166. [PubMed] [Google Scholar]
- Solovey A., Lin Y., Browne P., Choong S., Wayner E., Hebbel R. P. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997 Nov 27;337(22):1584–1590. doi: 10.1056/NEJM199711273372203. [DOI] [PubMed] [Google Scholar]
- Thiruvikraman S. V., Guha A., Roboz J., Taubman M. B., Nemerson Y., Fallon J. T. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest. 1996 Oct;75(4):451–461. [PubMed] [Google Scholar]
- Wilcox J. N., Smith K. M., Schwartz S. M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2839–2843. doi: 10.1073/pnas.86.8.2839. [DOI] [PMC free article] [PubMed] [Google Scholar]